Pay in 4 interest-free payments of $6.32 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
BPC-157 is under FDA advisory review in July 2026, and FDA staff documents recommend caution because human safety and effectiveness data are limited
Relevant people Maximilian Martin@max_enhancedFollow 29 | NYC Co-Founder & CEO @enhanced_games Redefining human performance Documenting the journey $ENHA Trending now
Some in vitro work suggests BPC 157 influences early growth response protein 1 (EGR-1), a transcription factor that regulates platelet-derived growth factor (PDGF), which in turn promotes fibroblast proliferation relevant to tendon and wound healing
Sermorelin and BPC-157 are often used together under medical guidance because they work in different ways
US$ 24.92
US$ 29.01
US$ 29.14
US$ 26.64
US$ 20.34
US$ 24.43
